Literature DB >> 3227000

Pulmonary hypoplasia in neonatal hypophosphatasia.

M M Silver1, G A Vilos, K J Milne.   

Abstract

Morphological, biophysical, and biochemical parameters of lung growth were studied at autopsy on a male infant with hypophosphatasia who died with asphyxia immediately after birth. The lungs were hypoplastic because of a marked decrease in airspace formation but lung maturation was normal for gestational age by all the parameters used. Diaphragmatic development, assessed by weight and fiber measurement, was in keeping with the decreased chest size. The proposed mechanism for this late onset type of pulmonary hypoplasia, attributed to decreased thoracic volume, is correlated with antenatal ultrasonographic observations of normal fetal breathing movements in the affected infant.

Entities:  

Mesh:

Year:  1988        PMID: 3227000     DOI: 10.3109/15513818809022304

Source DB:  PubMed          Journal:  Pediatr Pathol        ISSN: 0277-0938


  15 in total

Review 1.  Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.

Authors:  Michael P Whyte
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

2.  Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide.

Authors:  Tatsuo Nishioka; Shunji Tomatsu; Monica A Gutierrez; Ken-ichi Miyamoto; Georgeta G Trandafirescu; Patricia L C Lopez; Jeffrey H Grubb; Rie Kanai; Hironori Kobayashi; Seiji Yamaguchi; Gary S Gottesman; Richard Cahill; Akihiko Noguchi; William S Sly
Journal:  Mol Genet Metab       Date:  2006-04-17       Impact factor: 4.797

3.  Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.

Authors:  Michael P Whyte; Cheryl Rockman-Greenberg; Keiichi Ozono; Richard Riese; Scott Moseley; Agustin Melian; David D Thompson; Nicholas Bishop; Christine Hofmann
Journal:  J Clin Endocrinol Metab       Date:  2015-11-03       Impact factor: 5.958

4.  Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth.

Authors:  Yoko Okazaki; Hiroyuki Kitajima; Narutaka Mochizuki; Taichi Kitaoka; Toshimi Michigami; Keiichi Ozono
Journal:  Eur J Pediatr       Date:  2015-10-12       Impact factor: 3.183

5.  Autosomal recessive hypophosphatasia manifesting in utero with long bone deformity but showing spontaneous postnatal improvement.

Authors:  David A Stevenson; John C Carey; Stephen P Coburn; Karen L Ericson; Janice L B Byrne; Steven Mumm; Michael P Whyte
Journal:  J Clin Endocrinol Metab       Date:  2008-06-17       Impact factor: 5.958

6.  Healthcare resource utilization in the management of hypophosphatasia in three patients displaying a spectrum of manifestations.

Authors:  Anjali B Daniel; Vrinda Saraff; Nick J Shaw; Robert Yates; M Zulf Mughal; Raja Padidela
Journal:  Orphanet J Rare Dis       Date:  2018-08-16       Impact factor: 4.123

7.  Large-scale in vitro functional testing and novel variant scoring via protein modeling provide insights into alkaline phosphatase activity in hypophosphatasia.

Authors:  Guillermo Del Angel; John Reynders; Christopher Negron; Thomas Steinbrecher; Etienne Mornet
Journal:  Hum Mutat       Date:  2020-03-18       Impact factor: 4.878

8.  Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study.

Authors:  Christine E Hofmann; Paul Harmatz; Jerry Vockley; Wolfgang Högler; Hideki Nakayama; Nick Bishop; Gabriel Á Martos-Moreno; Scott Moseley; Kenji P Fujita; Johannes Liese; Cheryl Rockman-Greenberg
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

Review 9.  Dental-craniofacial manifestation and treatment of rare diseases.

Authors:  En Luo; Hanghang Liu; Qiucheng Zhao; Bing Shi; Qianming Chen
Journal:  Int J Oral Sci       Date:  2019-02-20       Impact factor: 6.344

10.  Development and validation of a modified performance-oriented mobility assessment tool for assessing mobility in children with hypophosphatasia.

Authors:  Dawn Phillips; Donna Griffin; Tracy Przybylski; Erica Morrison; Amy L Reeves; Marc Vallee; Kenji P Fujita; Katherine L Madson
Journal:  J Pediatr Rehabil Med       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.